Viviane Labrie
20 results.
In honor of World Parkinson’s Day, we asked scientists in our Center for Neurodegenerative Science what makes them most hopeful and most excited for the…
The first Van Andel Institute Public Lecture featured researchers who are on the frontlines in the search for more effective Parkinson’s disease treatments. Attendees heard…
Frequently thought of as a throwaway organ, the appendix may hold the key to better understanding and better treating the second-most common neurodegenerative disease When…
GRAND RAPIDS, Mich. (Oct. 31, 2018) — Removing the appendix early in life reduces the risk of developing Parkinson’s disease by 19 to 25 percent,…
Did you miss Grand Challenges in Parkinson’s Disease and Rallying to the Challenge? Don’t worry. We have you covered. Just over a week ago, the…
Dr. Viviane Labrie leads a lab in Van Andel Research Institute’s Center for Neurodegenerative Science. Her team studies the dynamic interplay between the human genome and its…
Scientists have a gut feeling about Parkinson’s disease. Namely, that it may not start in the brain, the organ most often associated with disease. Instead,…
For the seven to 10 million people worldwide with Parkinson’s disease, a medication that actually slows down their disease and staves off its debilitating symptoms…